1. Bartsch,H., Nair,U., Risch,A., Rojas,M. Wikman,H. and Alexandrov.K. (
2000
) Genetic polymorphism of
CYP
genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Cancer Epidemiol. Biomarkers Prev.
,
9
,
3
–28.
2. Gonzalez,F.J. and Gelboin,H.V. (
1994
) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.
Drug Metab. Rev.
,
26
,
165
–183.
3. Hukkanen,J., Pelkonen,O., Hakkola,J. and Raunio,H. (
2002
) Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung.
Crit. Rev. Toxicol.
,
32
,
391
–411.
4. Spivack,S.D., Hurteau,G.J., Reilly,A.A., Aldous,K.M., Ding,X. and Kaminsky,L.S. (
2001
) CYP1B1 expression in human lung.
Drug Metab. Dispos.
,
29
,
916
–922.
5. Song,N., Tan,W., Xing,D. and Lin,D. (
2001
) CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case–control study in China.
Carcinogenesis
,
22
,
11
–16.